Click for best price
Postpemic Era Small Molecule Targeted Cancer Therapy Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Small Molecule Targeted Cancer Therapy Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Small Molecule Targeted Cancer Therapy industry at home and abroad, estimate the overall market scale of the Small Molecule Targeted Cancer Therapy industry and the market share of major countries, Small Molecule Targeted Cancer Therapy industry, and study and judge the downstream market demand of Small Molecule Targeted Cancer Therapy through systematic research, Analyze the competition pattern of Small Molecule Targeted Cancer Therapy, so as to help solve the pain points of various stakeholders in Small Molecule Targeted Cancer Therapy industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Small Molecule Targeted Cancer Therapy Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Small Molecule Targeted Cancer Therapy Market?
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
Major Type of Small Molecule Targeted Cancer Therapy Covered in XYZResearch report:
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Application Segments Covered in XYZResearch Market
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Small Molecule Targeted Cancer Therapy Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
84 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Small Molecule Targeted Cancer Therapy Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Small Molecule Targeted Cancer Therapy Market by Value
2.2.1 Global Small Molecule Targeted Cancer Therapy Revenue by Type
2.2.2 Global Small Molecule Targeted Cancer Therapy Market by Value
2.3 Global Small Molecule Targeted Cancer Therapy Market by Sales
2.3.1 Global Small Molecule Targeted Cancer Therapy Sales by Type
2.3.2 Global Small Molecule Targeted Cancer Therapy Market by Sales
3. The Major Driver of Small Molecule Targeted Cancer Therapy Industry
3.1 Historical & Forecast Global Small Molecule Targeted Cancer Therapy Sales and Revenue (2018-2028)
3.2 Largest Application for Small Molecule Targeted Cancer Therapy (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Small Molecule Targeted Cancer Therapy Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Small Molecule Targeted Cancer Therapy Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Small Molecule Targeted Cancer Therapy Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Small Molecule Targeted Cancer Therapy Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Small Molecule Targeted Cancer Therapy Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Small Molecule Targeted Cancer Therapy Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Small Molecule Targeted Cancer Therapy Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Small Molecule Targeted Cancer Therapy Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Small Molecule Targeted Cancer Therapy Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Small Molecule Targeted Cancer Therapy Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Small Molecule Targeted Cancer Therapy Average Price Trend
13.1 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in US (2018-2022)
13.2 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in Europe (2018-2022)
13.3 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in China (2018-2022)
13.4 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in Japan (2018-2022)
13.5 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in India (2018-2022)
13.6 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in Korea (2018-2022)
13.7 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Small Molecule Targeted Cancer Therapy in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Small Molecule Targeted Cancer Therapy Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Small Molecule Targeted Cancer Therapy
15. Small Molecule Targeted Cancer Therapy Competitive Landscape
15.1 OncoGenex Pharmaceuticals, Inc.
15.1.1 OncoGenex Pharmaceuticals, Inc. Company Profiles
15.1.2 OncoGenex Pharmaceuticals, Inc. Product Introduction
15.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Cytokinetics Inc.
15.2.1 Cytokinetics Inc. Company Profiles
15.2.2 Cytokinetics Inc. Product Introduction
15.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Hospira Inc.
15.3.1 Hospira Inc. Company Profiles
15.3.2 Hospira Inc. Product Introduction
15.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 GlaxoSmithKline plc
15.4.1 GlaxoSmithKline plc Company Profiles
15.4.2 GlaxoSmithKline plc Product Introduction
15.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Boehringer Ingelheim GmbH
15.5.1 Boehringer Ingelheim GmbH Company Profiles
15.5.2 Boehringer Ingelheim GmbH Product Introduction
15.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Bayer HealthCare AG
15.6.1 Bayer HealthCare AG Company Profiles
15.6.2 Bayer HealthCare AG Product Introduction
15.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Abbott Laboratories
15.7.1 Abbott Laboratories Company Profiles
15.7.2 Abbott Laboratories Product Introduction
15.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Small Molecule Targeted Cancer Therapy Industry (Volume)
Figure 2. Small Molecule Targeted Cancer Therapy Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2022
Figure 5. US Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Small Molecule Targeted Cancer Therapy Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Small Molecule Targeted Cancer Therapy Revenue, by Type (Million USD) (2018-2028)
Table 4. Small Molecule Targeted Cancer Therapy Sales, by Type (K Unit) (2018-2028)
Table 5. Small Molecule Targeted Cancer Therapy Sales (K Unit) by Application (2018-2028)
Table 6. Small Molecule Targeted Cancer Therapy Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Small Molecule Targeted Cancer Therapy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Small Molecule Targeted Cancer Therapy in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. OncoGenex Pharmaceuticals, Inc. Profiles
Table 61. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product Introduction
Table 62. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. OncoGenex Pharmaceuticals, Inc. Strategic initiatives
Table 64. Cytokinetics Inc. Profiles
Table 65. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product Introduction
Table 66. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Cytokinetics Inc. Strategic initiatives
Table 68. Hospira Inc. Profiles
Table 69. Hospira Inc. Small Molecule Targeted Cancer Therapy Product Introduction
Table 70. Hospira Inc. Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Hospira Inc. Strategic initiatives
Table 72. GlaxoSmithKline plc Profiles
Table 73. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product Introduction
Table 74. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. GlaxoSmithKline plc Strategic initiatives
Table 76. Boehringer Ingelheim GmbH Profiles
Table 77. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product Introduction
Table 78. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Boehringer Ingelheim GmbH Strategic initiatives
Table 80. Bayer HealthCare AG Profiles
Table 81. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product Introduction
Table 82. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bayer HealthCare AG Strategic initiatives
Table 84. Abbott Laboratories Profiles
Table 85. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Introduction
Table 86. Abbott Laboratories Small Molecule Targeted Cancer Therapy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Abbott Laboratories Strategic initiatives
